WallStreetZenWallStreetZen

NASDAQ: RVMD
Revolution Medicines Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RVMD

Based on 19 analysts offering 12 month price targets for Revolution Medicines Inc

Min Forecast
$171.00-3.91%
Avg Forecast
$248.00+39.36%
Max Forecast
$320.00+79.82%

Should I buy or sell RVMD stock?

Based on 20 analysts offering ratings for Revolution Medicines Inc.

Strong Buy
Strong Buy
10 analysts 50%
Buy
9 analysts 45%
Hold
1 analysts 5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RVMD's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RVMD as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their RVMD stock forecasts and price targets.

RVMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-19
lockedlocked$00.00+00.00%2026-10-16
lockedlocked$00.00+00.00%2026-10-15
lockedlocked$00.00+00.00%2026-10-14
lockedlocked$00.00+00.00%2026-09-28
Goldman Sachs
Top 23%
78
Strong BuyReinstates$267.00+50.03%2026-09-24
Bank of America
Bottom 1%
1
Strong BuyMaintains$265.00+48.91%2026-09-21
Morgan Stanley
Top 31%
70
Strong BuyInitiates Coverage On$255.00+43.29%2026-09-10
Stifel Nicolaus
Top 11%
90
Strong BuyMaintains$230.00+29.24%2026-09-09Find out why
UBS
Top 11%
90
Strong BuyMaintains$265.00+48.91%2026-08-28

1 of 2

Forecast return on equity

Is RVMD forecast to generate an efficient return?

Company
25.28%
Industry
25.06%
Market
177.77%
RVMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RVMD forecast to generate an efficient return on assets?

Company
15.24%
Industry
23.99%
RVMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RVMD earnings per share forecast

What is RVMD's earnings per share in the next 3 years based on estimates from 26 analysts?

Avg 1 year Forecast
-$9.79
Avg 2 year Forecast
-$6.38
Avg 3 year Forecast
-$3.15

RVMD revenue forecast

What is RVMD's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$176.5M
Avg 2 year Forecast
$1.2B
Avg 3 year Forecast
$2.5B

RVMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RVMD$177.96$248.00+39.36%Strong Buy
RPRX$60.96$64.17+5.26%Strong Buy
ONC$369.06$421.36+14.17%Strong Buy
ALNY$231.83$354.06+52.72%Strong Buy
ARGX$819.14$1,158.88+41.47%Strong Buy
View Top Biotech Stocks

Revolution Medicines Stock Forecast FAQ

Is Revolution Medicines Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 20 Wall Street analysts covering (NASDAQ: RVMD) stock is to Strong Buy RVMD stock.

Out of 20 analysts, 10 (50%) are recommending RVMD as a Strong Buy, 9 (45%) are recommending RVMD as a Buy, 1 (5%) are recommending RVMD as a Hold, 0 (0%) are recommending RVMD as a Sell, and 0 (0%) are recommending RVMD as a Strong Sell.

If you're new to stock investing, here's how to buy Revolution Medicines stock.

What is RVMD's earnings growth forecast for 2026-2028?

(NASDAQ: RVMD) Revolution Medicines's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.78%.

Revolution Medicines's earnings in 2026 is -$1,768,285,000.On average, 26 Wall Street analysts forecast RVMD's earnings for 2026 to be -$2,098,482,134, with the lowest RVMD earnings forecast at -$2,594,113,667, and the highest RVMD earnings forecast at -$1,755,415,263. On average, 25 Wall Street analysts forecast RVMD's earnings for 2027 to be -$1,367,830,719, with the lowest RVMD earnings forecast at -$1,963,964,598, and the highest RVMD earnings forecast at -$432,102,219.

In 2028, RVMD is forecast to generate -$675,674,124 in earnings, with the lowest earnings forecast at -$2,140,406,337 and the highest earnings forecast at $1,201,784,296.

What is RVMD's revenue growth forecast for 2026-2028?

(NASDAQ: RVMD) Revolution Medicines's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.

Revolution Medicines's revenue in 2026 is $0.On average, 24 Wall Street analysts forecast RVMD's revenue for 2026 to be $37,834,664,505, with the lowest RVMD revenue forecast at $0, and the highest RVMD revenue forecast at $76,203,026,692. On average, 24 Wall Street analysts forecast RVMD's revenue for 2027 to be $255,060,337,420, with the lowest RVMD revenue forecast at $63,014,906,892, and the highest RVMD revenue forecast at $468,110,736,912.

In 2028, RVMD is forecast to generate $541,413,791,868 in revenue, with the lowest revenue forecast at $273,064,596,532 and the highest revenue forecast at $1,006,738,155,346.

What is RVMD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: RVMD) forecast ROA is 15.24%, which is lower than the forecast US Biotechnology industry average of 23.99%.

What is RVMD's Price Target?

According to 19 Wall Street analysts that have issued a 1 year RVMD price target, the average RVMD price target is $248.00, with the highest RVMD stock price forecast at $320.00 and the lowest RVMD stock price forecast at $171.00.

On average, Wall Street analysts predict that Revolution Medicines's share price could reach $248.00 by Oct 16, 2027. The average Revolution Medicines stock price prediction forecasts a potential upside of 39.36% from the current RVMD share price of $177.96.

What is RVMD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: RVMD) Revolution Medicines's current Earnings Per Share (EPS) is -$8.85. On average, analysts forecast that RVMD's EPS will be -$9.79 for 2026, with the lowest EPS forecast at -$12.10, and the highest EPS forecast at -$8.19. On average, analysts forecast that RVMD's EPS will be -$6.38 for 2027, with the lowest EPS forecast at -$9.16, and the highest EPS forecast at -$2.02. In 2028, RVMD's EPS is forecast to hit -$3.15 (min: -$9.99, max: $5.61).

What is RVMD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: RVMD) forecast ROE is 25.28%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.